Mantadix

Amantadine Hydrochloride, the active ingredient in Mantadix, is an antiviral presented as an oral tablet for oral use. It is employed in the management of influenza A infection, Parkinson's disease, and drug‑induced extrapyramidal symptoms.\n\nGNH India supplies Mantadix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mantadix is an antiviral and antiparkinsonian agent that acts on viral replication and dopaminergic pathways.\n\n- Influenza A infection: reduces viral replication and shortens illness duration.\n- Parkinson's disease: improves motor function by enhancing dopamine release.\n- Drug‑induced extrapyramidal symptoms: alleviates movement disorders caused by antipsychotic medications.

Common Side Effects:\n- Nausea: mild to moderate gastrointestinal upset.\n- Dizziness: transient light‑headedness, especially on standing.\n- Insomnia: difficulty initiating or maintaining sleep.\n- Headache: mild to moderate tension‑type pain.\n- Constipation: reduced bowel motility.\n- Anxiety: increased nervousness or restlessness.\n\nSerious or Rare Side Effects:\n- Hallucinations: visual or auditory disturbances requiring medical review.\n- Livedo reticularis: mottled skin discoloration.\n- Severe allergic reactions: rash, swelling, or anaphylaxis.\n- Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability.

Before initiating Mantadix, consider patient‑specific factors and monitor for adverse reactions.\n\n- Renal impairment: adjust dose or monitor renal function closely.\n- Pre‑existing CNS disorders: use caution in patients with seizures or severe psychiatric disease.\n- Cardiac disease: monitor for arrhythmias in patients with known conduction abnormalities.\n- Pregnancy: safety not established; prescribe only if potential benefit justifies risk.\n- Breastfeeding: unknown excretion; weigh benefits against possible infant exposure.\n- Store at room temperature: keep in the original container, protect from moisture and light.

Amantadine may interact with several medication classes, requiring careful assessment.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: risk of hypertensive crisis.\n- Anticholinergic agents: may reduce therapeutic benefit in Parkinsonian patients.\n- CNS depressants: additive sedation or respiratory depression.\n\nModerate Interactions (Monitor Closely):\n- Other dopaminergic drugs: potential for excessive dopaminergic stimulation.\n- Antiviral agents (e.g., rimantadine): competitive inhibition may alter efficacy.\n- Diuretics: may increase risk of electrolyte imbalance.